2 billion net inflow in August, pushing the Nifty 50 higher and narrowing the gap with global markets. The surge followed a period of outflows and marked the first month of the quarter where foreign money has consistently added to Indian stocks, raising expectations of a third straight month of buying in September. Sectoral data showed that Consumer Services, Financials and Healthcare were the primary beneficiaries, as foreign funds chased higher earnings and defensive growth stories.
The tilt towards banks and insurers reflected confidence in the banking sector’s asset quality, while pharma and health‑care stocks attracted attention after strong export demand and robust pipeline announcements. HSBC’s research notes that if global fund managers restore a neutral allocation to emerging markets, as much as $25 billion could flow into India over the next year. The outlook is underpinned by India’s resilient GDP growth, solid corporate earnings and a relatively stable rupee, all of which make the market attractive compared with many developed economies still grappling with higher inflation and rate hikes.
For the average Indian investor, the renewed foreign interest could translate into tighter market valuations and lower volatility, but it also means that a sudden reversal would impact portfolio performance. Retail investors are advised to stay diversified, keep an eye on sectoral trends, and consider the longer‑term growth story rather than short‑term market swings.